Immunization News and Research

RSS

Late-liver-stage malaria vaccine delivers 89% protection and boosts cellular immunity

Genetically attenuated malaria parasites with extended liver-stage arrest (GA2) showed 89% protection in a clinical trial, surpassing earlier vaccine candidates and highlighting the potential of cellular immunity.

26 Nov 2024

WHO grants Emergency Use Listing for LC16m8 mpox vaccine

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's declaration of an mpox public health emergency of international concern (PHEIC) on 14 August 2024.

19 Nov 2024

New nasal vaccine could help stop the spread of whooping cough

As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease.

19 Nov 2024

Measles outbreaks increase worldwide with inadequate immunization coverage

Worldwide, there were an estimated 10.3 million cases of measles in 2023, a 20% increase from 2022, according to new estimates from the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). Inadequate immunization coverage globally is driving the surge in cases.

14 Nov 2024

Maternal RSV vaccination timing optimizes newborn immunity through improved antibody transfer

Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at least five weeks before delivery.

14 Nov 2024

Inequities in COVID-19 vaccination coverage for older adults highlighted in global study

Researchers provide a global overview of COVID-19 vaccination programs among the elderly.

13 Nov 2024

Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17

Research indicates the Pfizer-BioNTech vaccine effectively reduces MIS-C incidence in children, supporting vaccination as a critical public health measure.

12 Nov 2024

Cleveland Clinic presents new findings on triple-negative breast cancer vaccine

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

8 Nov 2024

Gaza completes second round of polio vaccination campaign despite conflict barriers

The second round of the polio vaccination campaign in the Gaza Strip was completed yesterday, with an overall 556 774 children under the age of 10 being vaccinated with a second dose of polio vaccine, and 448 425 children between 2- to 10-years-old receiving vitamin A, following the three phases conducted in the last weeks.

6 Nov 2024

How a ketogenic diet could reduce autoimmune disease severity through host-microbiome interactions

This study uncovers the ketogenic diet's effects on the microbiome, revealing its potential to mitigate autoimmune diseases through metabolic pathways.

6 Nov 2024

WHO study names top pathogens in need of new vaccines

A new World Health Organization (WHO) study published today in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development.

5 Nov 2024

VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics discovery, and Fina Biosolutions LLC (FinaBio), experts in conjugate vaccine development and conjugate chemistry, today announced the signing of a joint IP and licensing agreement.

From VALANX Biotech 31 Oct 2024

Study highlights importance of RSV vaccination for high-risk populations

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines.

28 Oct 2024

WHO and Saudi Arabia announce new digital health collaboration to support Hajj pilgrims

The World Health Organization (WHO) and the Kingdom of Saudi Arabia announced a new milestone digital health collaboration today to expand the Hajj health card initiative to support the roughly 3 million pilgrims who undertake the holy pilgrimage every year.

22 Oct 2024

New single-chain mRNA vaccines offer enhanced immunity and protection against mpox

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant advancement in vaccine technology.

22 Oct 2024

Real world data highlights effectiveness of RSV vaccine

A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV -- short for respiratory syncytial virus -- vaccine.

18 Oct 2024

A review of clinical features, diagnosis, and management of Mpox

A comprehensive review in JAMA outlines monkeypox's clinical presentation and management, stressing the need for increased surveillance and vaccination efforts.

17 Oct 2024

Study provides detailed analysis of mRNA vaccine circulation and breakdown

A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream.

16 Oct 2024

Research links COVID-19 vaccines to temporary facial palsy in over 5,000 patients

This research identifies a potential link between COVID-19 vaccines and facial palsy, calling for enhanced surveillance and understanding of vaccine safety.

15 Oct 2024

WHO report highlights the role of vaccines in reducing antibiotic use

A new report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR).

10 Oct 2024